isoxazoles has been researched along with Anxiety Disorders in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alzarea, S; Rahman, S | 1 |
Anderer, P; Assandri, A; Nannipieri, F; Nessi, P; Rosini, S; Saletu, B; Saletu-Zyhlarz, GM; Semlitsch, HV; Wolzt, M | 1 |
Kinrys, G; Nery, F; Vasconcelos e Sa, D | 1 |
Hoehn-Saric, R | 1 |
1 trial(s) available for isoxazoles and Anxiety Disorders
Article | Year |
---|---|
Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Brain; Brain Mapping; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Humans; Isoxazoles; Male; Placebos; Psychomotor Performance; Time Factors | 2009 |
3 other study(ies) available for isoxazoles and Anxiety Disorders
Article | Year |
---|---|
Alpha-7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide-induced anxiety, cognitive deficit and depression-like behaviors in mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antidepressive Agents; Anxiety; Anxiety Disorders; Astrocytes; Cognition; Cognition Disorders; Cognitive Dysfunction; Cytokines; Depression; Depressive Disorder, Major; Disease Models, Animal; Hippocampus; Inflammation; Isoxazoles; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Phenylurea Compounds; Prefrontal Cortex | 2019 |
Adjunctive zonisamide for treatment refractory anxiety.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Cohort Studies; Female; Humans; Isoxazoles; Male; Middle Aged; Pilot Projects; Recurrence; Severity of Illness Index; Treatment Outcome; Zonisamide | 2007 |
Effects of THIP on chronic anxiety.
Topics: Adult; Anxiety Disorders; Female; Humans; Isoxazoles; Male; Middle Aged; Oxazoles; Psychiatric Status Rating Scales | 1983 |